" /> Fragile X tremor/ataxia syndrome - CISMeF





Preferred Label : Fragile X tremor/ataxia syndrome;

Symbol : FXTAS;

CISMeF acronym : FXTAS;

Type : Phenotype, molecular basis known;

Description : Jacquemont et al. (2007) provided a review of fragile X syndrome, which they characterized as a neurodevelopmental disorder, and FXTAS, which they characterized as a neurodegenerative disorder. Amiri et al. (2008) provided a review of FXTAS and noted that the pathogenesis of the disorder is distinct from that in fragile X syndrome. FXTAS results form a toxic gain of function of FMR1 RNA, whereas fragile X syndrome results from a loss of FMR1 function. The penetrance of FXTAS in male carriers aged 50 years and over, ascertained through families with a fragile X syndrome proband, is at least 33% (Hagerman and Hagerman, 2004); its penetrance in female carriers is approximately 5-10% (Greco et al., 2008).;

Inheritance : X-linked dominant;

Molecular basis : Caused by trinucleotide repeat expansion (CGG)n in the fragile site mental retardation gene (FMR1, 309550.0004);

Laboratory abnormalities : Increased intracellular FMRP mRNA; Decreased intracellular FMR protein;

Prefixed ID : #300623;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.